Frequently asked questions
Answers to the questions we are asked most often.
Getting started
Your data and who can see it
All uploads logged within a Lab are end-to-end encrypted, meaning the raw research data is never exposed to Molecule or to the public discovery feed. . This architecture lets researchers maintain full custody of sensitive IP while still publishing a transparent, auditable record of the research lifecycle for funders and the broader community to follow.
Proving what happened
Funding and reporting
Researchers create utility tokens for people interested in their project. The community and funders can purchase these tokens and provide direct input, with the ability to participate in projects at an equity level if qualified.
Our real-world-asset legal structure is available to integrate traditional corporate frameworks with cryptographic tokens—enhancing compliance, tax efficiency, and investor appeal while preserving the ethos of decentralization.
Coin-to-Company
About Molecule
Molecule enables early-stage research with a clear path to commercialization.
Our technology has proven most successful in four key areas:
- Regenerative Medicine: Longevity, Cryopreservation, Spine Health
- Neuroscience: Brain Health, Psychedelics, Cognitive Enhancement
- Frontier Biology: Quantum & Synthetic Biology
- Underfunded Areas: Women’s Health, Rare Diseases, Long Covid
Molecule is a first mover and market leader in the Decentralized Science ecosystem, operating since 2019.
Molecule founded leading DeSci organizations BIO Protocol, VitaDAO and pump.science. Collectively, we’ve received backing from Northpond Ventures, Pfizer Ventures, Balaji Srinivasan, Yzi Labs, Shine Capital, Maelstrom, and more.
Our novel model has been published in Nature Biotechnology and featured in the Stanford Law Review and Forbes.